165 An Analysis of the Use of Andexanet Alfa at the University of Utah Hospital
Introduction: Andexanet alfa is used to reverse the effects of apixaban and rivaroxaban but increases the risk of thrombosis, and there is a need for more real-world evidence evaluating andexanet use. The objective of this study was to assess the usage and outcomes of andexanet at the University of Utah Medical Center.
Authors
- Daniel M. Witt (ORCID: https://orcid.org/0000-0002-3930-8358)
- James R. Gustat
- Aubrey E. Jones
Institutions
- University of Utah (US)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102814
- Primary Topic
- Medical Device Sterilization and Disinfection
- Type
- article
- Field-Weighted Citation Impact
- 0.00